With fewer Part D plans and a $2,000 out-of-pocket cap, beneficiaries must rethink their Medicare drug coverage for 2025.
The Inflation Reduction Act (the Act) of 2022 was controversial at the time the Act was signed into law and remains so. To date, multiple ...
Congress recently made a number of changes to Medicare's "Part D" prescription drug benefit. The changes were part of President Joe Biden's signature legislation, the Inflation Reduction Act. The legi ...
President-elect Donald Trump has nominated Dr. Mehmet Oz to lead the Centers for Medicare and Medicaid Services (CMS), ...
With policy makers focusing on the role of drug manufacturers, almost no attention has been paid to the way in which ...
The U.S. pharmaceutical industry is attempting to delay the timeline for Medicare's drug price negotiations following the ...
A record-low number of Medicare Part D plans could cause greater Medicare Advantage enrollment, which may not be a good thing ...
The U.S. pharmaceutical industry is pushing to revamp the new law that allows Medicare to negotiate prices for its costliest ...
The panel focused on the provisions of the Inflation Reduction Act that aim to lower prescription drug prices under Medicare.
Seniors in metro Detroit and across Michigan have an opportunity to sign up for the right Medicare plan during open ...
If confirmed to run the Centers for Medicare & Medicaid Services, television personality Dr. Mehmet Oz, President-elect ...
It’s a scary time in American politics. The results of the November election are discouraging to many Indianapolis residents.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback